High-Efficiency Bohle Tablet Coater - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

High-Efficiency Bohle Tablet Coater


L.B. Bohle has developed the future of tablet coating, the high-efficiency Bohle Tablet Coater (BTC). The tablet coater reduces processing times up to 35 percent compared to conventional tablet coating systems, yielding significant cost savings and improved campaign efficiency while maintaining cGMP standards.

The BTC provides superior coating uniformity, producing considerably fewer rejects and using less coating material. L.B. Bohle’s patented air flow bed technology eliminates spray drying, thereby reducing waste while lengthening campaigns between cleaning. It also promotes uniform tablet coating with a high-quality, defect-free film coat.

The tablet coater’s elongated coating pan provides a larger tablet spraying surface accommodating up to 10 spray nozzles, which delivers more suspension solution and reduces overall coating time. The BTC’s integrated mixing baffles are double-helix shaped to ensure thorough tablet mixing with gentle handling. The baffle design provides 100-percent tablet discharge, increasing campaign efficiency.

The BTC is ergonomically designed for efficient material handling and is capable of Wash-in-Place (WIP) cleaning. The BTC spray arm and nozzles are mounted on the front door assembly, simplifying inspection and maintenance.

 

The L.B. Bohle Coating products:

  • Bohle Tablet Coater BTC
  • Bohle Film Coater BFC TriPan
  • Bohle Film Coater BFC

Contact:
Tobias Borgers
Head of Marketing
Phone: +49 25 24 - 93 23 0
Fax: +49 25 24 - 93 23 399
Email: t.borgers@lbbohle.de
Web: www.lbbohle.com

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here